Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Hypertension, Portal
- TIPS Plus Cadonilimab in Advanced HCC With Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study
- Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.
- LiveSMART Trial to Prevent Falls in Patients With Cirrhosis
- Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.
- Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
- The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study
- Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial
- Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
- Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection
- A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to th
- Vonoprazan Efficacy to Prevent Post Variceal Band Ligation Ulcer
- A Study to Test Whether Two Different Doses of BI 685509 Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)
- Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
- Extension Study of Carvedilol RCT Study
- Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
- Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension
- SHAPE of Portal Hypertension in Children
- EUS-guided PSE in Combination With EUS-guided Treatment of Varices for Patients With Portal Hypertension
- Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)
- Primary Prophylaxis for Variceal Bleed in Biliary Atresia
- Anticoagulation Therapy After Splenectomy in Cirrhosis Patient
- Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.
- Ivabradine in Cirrhotic Cardiomyopathy
- Somatostatin in Living Donor Liver Transplantation
- Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
- The Role of Somatostatin in the Hemodynamics of the Hepatic Circulation in Patients Undergoing Liver Resection
- Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension
- A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis
- HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803)
- Carvedilol for Prevention of Esophageal Varices Progression
- Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension
- Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14
- PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)
- The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices
- Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction
- Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis
- 8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding in Patients With Child A Cirrhosis
- Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After Simvastatin
- Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal Hypertension
- Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
- Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and Entecavir
- Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir
- A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal Hypertension
- Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS
- Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis
- TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV
- Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
- Serelaxin To Lower Portal Pressure
- Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices
- Surrogate Markers of Portal Pressure
- Cavernous Transformation of Portal Vein: Etiology, Diagnosis, Management and Prognosis
- Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension
- 3D CT Guidance for Transjugular Intrahepatic Portosystemic Shunt Creation
- 8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding
- To Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices.
- Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
- Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis
- A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
- Simvastatin Effect on Portal Hypertension
- Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding
- Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric Varices
- Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients
- Quality of Life and Nutritional Improvements in Cirrhotic Patients
- The Effect of Sorafenib on Portal Pressure
- Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
- An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension
- Probiotics for Liver Cirrhosis With Portal Hypertension
- Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension
- The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
- Evaluation of Efficacy and Safety of Somatostatin Used as Inflow Modulator in Liver Transplantation.
- Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis
- Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertension
- A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding
- Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
- Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
- Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding
- RCT of Carvedilol Versus Variceal Band Ligation in the Primary Prophylaxis of Oesophageal Variceal Haemorrhage
- Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
- The Effect of Probiotics (VSL) on Portal Hypertension
- Comparison of Endoscopic Variceal Ligation (EVL) With Propranolol in Non Cirrhotic Portal Hypertension (NCPH)
- Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE
- Endoscopic Variceal Ligation (EVL)+ Drugs Versus Endoscopic Variceal Ligation (EVL) Alone For Secondary Prophylaxis
- Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
- Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension
- Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis
- The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed
- Danish Carvedilol Study in Portal Hypertension
- Secondary Prophylaxis After Variceal Bleeding in Non-Responders
- Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure
- Short Course Terlipressin for Control of Acute Variceal Bleeding
- Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis
- Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
- Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C
- Vasoactive Peptides in Portal Pressure
- Prevention of Esophageal Varices by Beta-Adrenergic Blockers
- Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
- Prevention of Esophageal Varices by Beta-Adrenergic Blockers